Literature DB >> 17954082

Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery.

Dana M Radu1, Françoise Jauréguy, Agathe Seguin, Clément Foulon, Marie Dominique Destable, Jacques Azorin, Emmanuel Martinod.   

Abstract

BACKGROUND: Antibiotics currently recommended for prophylaxis in thoracic surgery are first-generation and second-generation cephalosporins. Despite this prophylaxis, postoperative pneumonia after major pulmonary resections remains frequent and severe. However, in the medical literature, the origin of these infections is poorly documented.
METHODS: To evaluate the efficiency of current prophylactic regimens, we retrospectively analyzed 312 consecutive cases of major pulmonary resection, performed between January 2000 and December 2004. For patients who experienced postoperative pulmonary infection, the microbiologic agents and their antibiotic susceptibility were studied.
RESULTS: A postoperative pneumonia was diagnosed in 76 patients (24.4% +/- 0.43%). Sixty patients (78.9%) experienced the infection in the first 5 postoperative days. A microbiologic documentation was obtained in 44 cases (57.9%) with 56 microorganisms involved. Pathogens responsible for the infections were Staphylococcus aureus (n = 10), Streptococcus pneumoniae (n = 8), group B Streptococcus organisms (n = 1), nongroupable Streptococcus organisms (n = 2), Enterococcus faecalis (n = 1), Haemophilus spp. (n = 9), Branhamella catarrhalis (n = 2), Enterobacteriaceae (n = 15), Pseudomonas aeruginosa (n = 3), Acinetobacter baumannii (n = 1), and Candida spp. (n = 4). According to the antibiotic susceptibility testings, the prophylactic regimen by cefazolin proved ineffective for 84% of the microbiologically documented cases.
CONCLUSIONS: This study confirmed the inefficiency of current prophylaxis against pathogens involved in postoperative pneumonia after major lung resections. Evaluation of new and more-adapted approaches of antibiotic prophylaxis should be the subject of prospective multicenter trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954082     DOI: 10.1016/j.athoracsur.2007.05.059

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period.

Authors:  Jiandong Mei; Lunxu Liu; Menglin Tang; Ninghui Xu; Qiang Pu; Chengwu Liu; Lin Ma; Hui Shi; Guowei Che
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  Impact of previous gastrectomy on postoperative pneumonia after pulmonary resection in lung cancer patients.

Authors:  Hiroyuki Kaneda; Takahito Nakano; Yohei Taniguchi; Tomohito Saito; Toshifumi Konobu; Yukihito Saito
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-14

3.  A Prediction Model for Postoperative Pulmonary Complication in Pulmonary Function-Impaired Patients Following Lung Resection.

Authors:  Xiaowei Mao; Wei Zhang; Yi-Qian Ni; Yanjie Niu; Li-Yan Jiang
Journal:  J Multidiscip Healthc       Date:  2021-11-15

Review 4.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

5.  Lung surgery in children and their post-operative risk of respiratory infection.

Authors:  Mark A Fleming; Thomas O Xu; Jeffrey W Gander; Daniel E Levin
Journal:  Pediatr Surg Int       Date:  2021-01-10       Impact factor: 1.827

6.  [Can Preoperative Peak Expiratory Flow Predict Postoperative Pulmonary Complications in Lung Cancer Patients Undergoing Lobectomy?]

Authors:  Kun Zhou; Yanming Wu; Jianhua Su; Yutian Lai; Cheng Shen; Pengfei Li; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-09-20

7.  Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer.

Authors:  Jan A Stratmann; Raphael Lacko; Olivier Ballo; Shabnam Shaid; Wolfgang Gleiber; Maria J G T Vehreschild; Thomas Wichelhaus; Claudia Reinheimer; Stephan Göttig; Volkhard A J Kempf; Peter Kleine; Susanne Stera; Christian Brandts; Martin Sebastian; Sebastian Koschade
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

8.  Chronic Progression of Lung Cancer Recurrence After Surgery: Warning Role of Postoperative Pneumonia.

Authors:  Dong-Qi Lin; Jin-Guo Zhu; Xiao-Hua Xu; Ke Xiao; Xu-Qing Wen; Qi-Fa Zheng; Yu-Hua Zhou; Xin-Ying Cai
Journal:  Cancer Manag Res       Date:  2021-09-24       Impact factor: 3.989

9.  Postoperative complications and perioperative management of lung resection in patients with a history of oesophagectomy for oesophageal carcinoma.

Authors:  Yukio Watanabe; Aritoshi Hattori; Shuko Nojiri; Mariko Fukui; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18

10.  Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.

Authors:  Chenchen Li; Xia Zhao; Yang Yang; Siwen Liu; Yun Liu; Xiaoyou Li
Journal:  Med Sci Monit       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.